Latest topics page 12
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 12 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Second pass at: What a 2 ppm match establishes, and what it does not
Second pass at: What a 2 ppm match establishes, and what it does not — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked.…
|
+44 | 49 | 8.1k | 1d |
|
What a certificate commits its issuer to — one year on
What a certificate commits its issuer to — one year on — that is the question, and I have not found it answered plainly anywhere I have looked. A documentation question rather than an analytical one. I have a…
|
+107 | 117 | 6.5k | 1d |
|
What a simple presence test is genuinely useful for
What a simple presence test is genuinely useful for — that is the question, and I have not found it answered plainly anywhere I have looked. Working through the identity arithmetic and I would like it…
|
2 | 58 | 1d | |
|
Revisiting: Can a home kit substitute for a laboratory report? A careful no
Revisiting: Can a home kit substitute for a laboratory report? A careful no — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it…
|
+50 | 56 | 9.8k | 1d |
|
Follow-up: Patterns that reliably precede a problem, documented
On the subject in the title: Patterns that reliably precede a problem, documented Working notes rather than a conclusion. A logistics question, since the answers here are usually better than anywhere else I…
|
2 | 70 | 1d | |
|
Tracking a shortage from primary sources rather than rumour — the long version
On the subject in the title: Tracking a shortage from primary sources rather than rumour — the long version Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in…
|
2 | 60 | 1d | |
|
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one — setting out what I have, and where I think it stops being reliable. Session topic: FLOW ( N Engl J Med , 2024). Please…
|
+25 | 29 | 22k | 1d |
|
Drawing up with one needle and injecting with another
On the subject in the title: Drawing up with one needle and injecting with another Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly these go…
|
+1 | 5 | 6.9k | 1d |
|
Revisiting: Theoretical plates: useful number or ritual?
Asking directly, because I could not find a straight answer: Revisiting: Theoretical plates: useful number or ritual? I would like to understand what this number means before I repeat it anywhere. A…
|
+16 | 21 | 1.2k | 1d |
|
Specificity, linearity, accuracy, precision, range, robustness — with real criteria
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this…
|
+44 | 48 | 12k | 1d |
|
Journal club: orforglipron phase 2 and the non-peptide question
Journal club: orforglipron phase 2 and the non-peptide question Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited in support…
|
+120 | 132 | 13k | 1d |
|
The report format the maintainers ask for, and why each field is there
On the subject in the title: The report format the maintainers ask for, and why each field is there Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
4 | 6.3k | 1d | |
|
Follow-up: How compounding permissions changed when supply normalised
How compounding permissions changed when supply normalised I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion, following the…
|
+72 | 77 | 1.5k | 1d |
|
What to bring: records that a clinician can actually use
Asking directly, because I could not find a straight answer: What to bring: records that a clinician can actually use Asking about a population rather than about a person. The published trials in this class…
|
+15 | 19 | 6.4k | 1d |
|
[2026 update] Second opinions: how to seek one without burning the first
On the subject in the title: Second opinions: how to seek one without burning the first Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the…
|
2 | 5.9k | 1d | |
|
[2026 update] Travelling with an injectable: documentation and practicalities
Travelling with an injectable: documentation and practicalities Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in…
|
+107 | 111 | 12k | 1d |
|
Coming back to: How much context is too much context in a first post?
Asking directly, because I could not find a straight answer: How much context is too much context in a first post? Question in the title. Context below, and I have tried to include the things people here…
|
+2 | 6 | 7.5k | 1d |
|
Sulfonylureas: the interaction most worth taking seriously — what changed since
On the subject in the title: Sulfonylureas: the interaction most worth taking seriously — what changed since Working notes rather than a conclusion. I have read the maintained page on this and I still have a…
|
+3 | 7 | 35k | 1d |
|
Mass error in ppm: the arithmetic and the caveat — a second dataset
On the subject in the title: Mass error in ppm: the arithmetic and the caveat — a second dataset Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked.…
|
+20 | 24 | 1.7k | 1d |
|
Irish differences from the UK position — what changed since
Irish differences from the UK position — what changed since — setting out what I have, and where I think it stops being reliable. Documenting an access outcome, dated, because everything in this category…
|
+8 | 12 | 782 | 1d |
|
A 5 mg vial and a 0.25 mg dose: the arithmetic in full
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
|
+124 | 141 | 16k | 2d |
|
Coming back to: Light exposure: how much protection is proportionate?
Asking directly, because I could not find a straight answer: Light exposure: how much protection is proportionate? Practical question with the units stated, because I have seen how quickly these go wrong…
|
+5 | 10 | 13k | 2d |
|
Follow-up: Reading an interaction checker output critically
Reading an interaction checker output critically — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I still have a gap, so I am asking rather…
|
+62 | 66 | 13k | 2d |
|
[2026 update] Regional warehouse stock versus direct despatch
Regional warehouse stock versus direct despatch Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than anywhere…
|
+135 | 147 | 32k | 2d |
|
Dizziness on standing: the ordinary explanation first — one year on
Dizziness on standing: the ordinary explanation first — one year on — setting out what I have, and where I think it stops being reliable. Longitudinal report with the method stated, because a number without a…
|
+12 | 16 | 1.1k | 2d |
|
Which categories are strict and which are relaxed, honestly
Which categories are strict and which are relaxed, honestly I have a specific reason for asking rather than idle curiosity, and the context is below. I want to check my reasoning rather than get a conclusion.…
|
+47 | 53 | 1.8k | 2d |
|
What to include when your question involves a laboratory result
Asking directly, because I could not find a straight answer: What to include when your question involves a laboratory result Question in the title. Context below, and I have tried to include the things people…
|
+8 | 12 | 14k | 2d |
|
Follow-up: The retatrutide phase 2 obesity paper, read closely
The retatrutide phase 2 obesity paper, read closely — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021) cited in support of a claim I do not think it…
|
+19 | 23 | 16k | 2d |
|
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit Writing it up because I had to work it out twice and would rather nobody else did. Comparing SURPASS-4 ( Lancet ,…
|
+50 | 55 | 7.8k | 2d |
|
Micro-titration: a disputed topic, argued properly
Micro-titration: a disputed topic, argued properly Writing it up because I had to work it out twice and would rather nobody else did. A question about technique rather than about dose. I have been doing the…
|
+99 | 110 | 61k | 2d |